Evidence map›Paper›PMID 31384699›Full record

ArticleAIMS microbiology2019

Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent

Marina Santiago, Lindsay Eysenbach, Jessica Allegretti, Olga Aroniadis, Lawrence J Brandt, Monika Fischer, Ari Grinspan, Colleen Kelly, Casey Morrow, Martin Rodriguez and 4 more

Open access · goldAbstract read
In one paragraph

Article in AIMS microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Marina SantiagoFinch Therapeutics, 200 Inner Belt Rd, Somerville, MA 02143, USA.
Lindsay EysenbachOpenBiome, 2067 Massachusetts Ave, Cambridge, MA 02140, USA.
Jessica AllegrettiDivision of Gastroenterology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.
Olga AroniadisDepartment of Medicine (Gastroenterology), Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Lawrence J BrandtDepartment of Medicine (Gastroenterology), Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Monika FischerDivision of Gastroenterology, Indiana University School of Medicine, 340 W. 10th St, Indianapolis, IN 46202, USA.
Ari GrinspanDivision of Gastroenterology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.
Colleen KellyWomen's Medicine Collaborative, Brown Alpert Medial School, 222 Richmond St, Providence, RI 02903, USA.
Casey MorrowDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, 1720 2nd Ave S, Birmingham, AL 35294, USA.
Martin RodriguezDivision of Infectious Diseases, University of Alabama at Birmingham School of Medicine, 1670 University Blvd, Birmingham, AL 35233, USA.
Majdi OsmanOpenBiome, 2067 Massachusetts Ave, Cambridge, MA 02140, USA.
Zain KassamFinch Therapeutics, 200 Inner Belt Rd, Somerville, MA 02143, USA.
Mark B SmithFinch Therapeutics, 200 Inner Belt Rd, Somerville, MA 02143, USA.
Sonia TimberlakeFinch Therapeutics, 200 Inner Belt Rd, Somerville, MA 02143, USA.
Brigham and Women's Hospital · USFinch Therapeutics (United States) · USAlbert Einstein College of Medicine · USBrown University · USOpenBiome · USUniversity of Alabama at Birmingham · USIndiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gastrointestinal microbiome is intrinsically linked to the spread of antibiotic resistance. Antibiotic treatment puts patients at risk for colonization by opportunistic pathogens like vancomycin resistant Enterococcus and

Indexed as

Clostridioides difficilefecal microbiota transplantmicrobiomevancomycin resistant Enterococcus

Identifiers

PMID31384699
PMCPMC6646931
OpenAlexW2911190614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.